| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Section of Neonatology and Pediatric Critical Care Medicine, Childrens Hospital; and Section of Pediatric Neurology, Department of Neurology (D.B.-K., H.H.) and Outpatient Department of Child and Adolescent Psychiatry, Department of Psychotherapy and Psychosomatic Medicine (G.S., M.O., B.K., K.-H.B.), University of Ulm, 89075 Ulm, Germany
Address all correspondence and requests for reprints to: Dr. Andreas Trotter, Section of Neonatology and Pediatric Critical Care Medicine, Childrens Hospital, University of Ulm, Prittwitzstrasse 43, 89075 Ulm, Germany. E-mail: andreas.trotter{at}medizin.uni-ulm.de
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The follow-up examination of the preterm infants in the pilot study aimed at exploring the potential midterm effects of postnatal E2 and P replacement on the bone mineral accretion, skeletal age, and neurological development.
| Materials and Methods |
|---|
|
|
|---|
From the 30 infants enrolled in the randomized controlled pilot study, 25 infants survived (E2 and P replacement group, n = 13; control group, n = 12). The parents of 24 infants agreed to the follow-up examination. Gestational age, body weight, body length, and head circumference at birth and at the end of the E2 and P replacement showed no statistical differences between the groups (5). The follow-up examination was performed at a median chronological age of 18.1 months (minimum-maximum, 17.020.6) corresponding to a corrected age of 14.8 months (minimum-maximum, 12.917.4).
Body weight, body length, and head circumference were measured. The current values were subtracted from the values obtained at the end of the E2 and P replacement period 6 weeks postnatally to calculate the monthly increases in somatic growth data.
Bone mineral content (BMC) was measured as described previously (6) using single photon absorption densitometry (model 278/C, Norland Corp., Fort Atkinson, WI). Because the BMC is highly correlated to the body weight (BW) (6), the BMC/BW ratio was calculated to compare the two groups. The bone mineral accretion (milligrams per cm per 100 g wt gain) was calculated as the difference between the two BMC measurements at the follow-up examination and at 6 weeks postnatally divided by the corresponding weight gain.
A radiograph of the left hand and wrist (distance to the cathode, 100 cm; voltage, 40 kV; amperage, 1.4 mAS) was performed to determine skeletal age according to the criteria defined by Greulich and Pyle (7). The age of each ossification center (distal epiphysis of the ulna and radius, carpal and meta-carpo-phalangeal bones, and phalanges) was determined, and the individual average skeletal age was calculated. This was performed by an experienced pediatric endocrinologist (W.S.).
The Bayley scales of infant development were used (8). The test was performed by a psychologist experienced in examining preterm infants. Using the corrected age, the raw scores of the mental and motor developmental tests were determined. These were then converted to index scores [mental developmental index (MDI) and psychomotor developmental index (PDI)] in which 100 represents the 50th percentile of a normative collective. Because MDI and PDI scores below 50 are not defined, they were recorded as a value of 49. The raw scores were extrapolated to a mental developmental age and a psychomotor developmental age, and the corrected age was subtracted from them.
A pediatric neurologist evaluated the function of the cranial nerves (IIXII), muscle tone, motor abilities, motor reflexes, coordination of movements, and brainstem functions. Based on a scoring system, the infants were classified into five groups that were defined as normal, questionably pathological, minor, moderate, or showing severe neurological deficit. The examiners for skeletal age, the Bayley test of infant development, and the neurological status were blind to the infants postnatal treatment.
Statistical analysis
The Mann-Whitney U test was used to compare the results of the study groups. P < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
The parents of one infant in the control group did not agree to a
radiograph of the left hand. Table 1
shows the skeletal age of each group. The median deviation of the
skeletal age from the corrected age of 1.7 months in the control
group indicates a delayed skeletal maturation. The median skeletal age
of the replacement group infants exactly fitted the corrected age
(P = 0.64).
|
|
|
| Discussion |
|---|
|
|
|---|
Neurological examination was normal in three infants in the E2 and P replacement group, but in none of the control group infants. For the control group infants, the median MDI and PDI scores were 93 and 71, corresponding to a median delay of 1.3 months for mental development and 3.7 months for motor development. The results are in accordance with previous findings in preterm infants and reflect the fact that preterm infants perform below their same postmenstrual age peers born at term (8). The median MDI score of the infants receiving postnatal E2 and P replacement was 89 and also lower than that of a normative sample. Interestingly, the replacement group achieved normal psychomotor development, with a median PDI score of 101. Estrogens have been discussed as possible trophic factors for developing neurons (10). They can promote axonal and dendritic growth and synapse formation (11) and thus can influence the development of neural networks.
No significant differences were found between the infants of the hormone replacement group and the control group infants, possibly due to the small sample size of the pilot study. Interestingly, normal PDI was found in the replacement group, whereas extremely preterm infants without hormone replacement most often showed a delay in psychomotor development. This preliminary data support the potentially important integrative role of sex steroids in the developing brain. Further studies of the effects of postnatal replacement of E2 and P in extremely preterm infants are warranted.
Received July 7, 2000.
Revised September 11, 2000.
Revised October 4, 2000.
Accepted October 19, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. C. McCurnin, R. A. Pierce, B. C. Willis, L. Y. Chang, B. A. Yoder, I. S. Yuhanna, P. L. Ballard, R. I. Clyman, N. Waleh, W. Maniscalco, et al. Postnatal Estradiol Up-regulates Lung Nitric Oxide Synthases and Improves Lung Function in Bronchopulmonary Dysplasia Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 492 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gellersen, M.S. Fernandes, and J.J. Brosens Non-genomic progesterone actions in female reproduction Hum. Reprod. Update, January 1, 2009; 15(1): 119 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Wagner Progesterone Receptors and Neural Development: A Gap between Bench and Bedside? Endocrinology, June 1, 2008; 149(6): 2743 - 2749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Trotter, L Maier, M Kron, and F Pohlandt Effect of oestradiol and progesterone replacement on bronchopulmonary dysplasia in extremely preterm infants Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2007; 92(2): F94 - F98. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Doan, S. Gagnon, and V. Joseph Prenatal blockade of estradiol synthesis impairs respiratory and metabolic responses to hypoxia in newborn and adult rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R612 - R618. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |